Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-04-08

FDA Approved: CLONAZEPAM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for clonazepam filed by Aurobindo Pharma Limited under ANDA075150.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonazepam (Clonazepam)

Snippet

SUPPL AP for CLONAZEPAM (CLONAZEPAM)